ACTION stands for Antenatal CorticosTeroids for Improving Outcomes in preterm Newborns. WHO is conducting this multi-country, multi-centre and randomized trial of two doses of antenatal corticosteroids for women with a high probability of birth in the late preterm period in hospitals to improve the health of newborns. Aim of this trial is to assess the benefits and possible harms of giving two regimens of antenatal corticosteroids to pregnant women between 34 weeks and 37 weeks when they are at risk of preterm birth. The researchers will also find out which steroids are suitable to save the lives of preterm babies. They will also try to know about the perfect doses for the safety of the mother and baby, said the official sources., ACTION stands for Antenatal CorticosTeroids for Improving Outcomes in preterm Newborns. WHO is conducting this multi-country, multi-centre and randomized trial of two doses of antenatal corticosteroids for women with a high probability of birth in the late preterm period in hospitals to improve the health of newborns. Aim of this trial is to assess the benefits and possible harms of giving two regimens of antenatal corticosteroids to pregnant women between 34 weeks and 37 weeks when they are at risk of preterm birth. The researchers will also find out which steroids are suitable to save the lives of preterm babies. They will also try to know about the perfect doses for the safety of the mother and baby, said the official sources., , Read More,
AAS Yoga
Go for Euphoria – Illness to Wellness the Natural Way